Home
Remus Pharmaceuticals Ltd 52 Week High

Remus Pharmaceuticals Ltd
NSE: RemusPharma.
YEARHIGH
Key Highlights
- The 52 Week HIGH of Remus Pharmaceuticals Ltd is ₹ 2834 as of 02 May 25 .
Company Fundamentals for Remus Pharmaceuticals Ltd
Market Price of Remus Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
02 May 2025 | 1981 |
30 Apr 2025 | 2020.4 |
29 Apr 2025 | 2078.1 |
28 Apr 2025 | 2025.1 |
25 Apr 2025 | 1903.6 |
24 Apr 2025 | 1956.35 |
23 Apr 2025 | 1997.1 |
22 Apr 2025 | 1995 |
21 Apr 2025 | 2036.55 |
17 Apr 2025 | 2004 |
Asset Value vs Market Value of Remus Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Remus Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Remus Pharmaceuticals Ltd
Historical Net Profit of Remus Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Remus Pharmaceuticals Ltd
Remus Pharmaceuticals Ltd News Hub
Remus Pharmaceuticals to convene AGM
Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be hel
Read more
31 Aug 24
Board of Remus Pharmaceuticals recommends interim dividend
Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9
Read more
09 Nov 24
Remus Pharmaceuticals to convene board meeting
Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 202
Read more
07 Nov 24